# Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

> **NCT01739244** · PHASE2 · COMPLETED · sponsor: **Sylentis, S.A.** · enrollment: 80 (actual)

## Conditions studied

- Ocular Hypertension
- Open Angle Glaucoma

## Interventions

- **DRUG:** SYL040012
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01739244
- **Lead sponsor:** Sylentis, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01739244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01739244, "Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01739244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*